0001798749-20-000002.txt : 20200814
0001798749-20-000002.hdr.sgml : 20200814
20200814154029
ACCESSION NUMBER: 0001798749-20-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200814
DATE AS OF CHANGE: 20200814
EFFECTIVENESS DATE: 20200814
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc.
CENTRAL INDEX KEY: 0001798749
IRS NUMBER: 831377888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-373292
FILM NUMBER: 201104647
BUSINESS ADDRESS:
STREET 1: C/O RA CAPITAL MANAGEMENT
STREET 2: 200 BERKELEY STREET, 18TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-778-2494
MAIL ADDRESS:
STREET 1: C/O RA CAPITAL MANAGEMENT
STREET 2: 200 BERKELEY STREET, 18TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
D
1
primary_doc.xml
X0708
D
LIVE
0001798749
Aerovate Therapeutics, Inc.
C/O RA CAPITAL MANAGEMENT
200 BERKELEY STREET, 18TH FLOOR
BOSTON
MA
MASSACHUSETTS
02116
617-778-2494
DELAWARE
None
None
Corporation
true
2018
Benjamin
T.
Dake
Aerovate Therapeutics Inc.
200 Berkeley Street, 18th Floor
Boston
MA
MASSACHUSETTS
02116
Executive Officer
Director
David
Grayzel
Aerovate Therapeutics Inc.
200 Berkeley Street, 18th Floor
Boston
MA
MASSACHUSETTS
02116
Director
Maha
Katabi
Aerovate Therapeutics Inc.
200 Berkeley Street, 18th Floor
Boston
MA
MASSACHUSETTS
02116
Director
Jonathan
Leff
Aerovate Therapeutics Inc.
200 Berkeley Street, 18th Floor
Boston
MA
MASSACHUSETTS
02116
Director
Joshua
Resnick
Aerovate Therapeutics Inc.
200 Berkeley Street, 18th Floor
Boston
MA
MASSACHUSETTS
02116
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2020-08-05
false
true
false
0
75818727
75818727
0
false
9
0
0
0
false
Aerovate Therapeutics, Inc.
Benjamin T. Dake
Benjamin T. Dake
President
2020-08-14